Abstract
Introduction: The VENTANA PD-L1 (SP263) Assay is approved for use with anti-programmed cell death-1/programmed cell death ligand-1 (PD-1/PD-L1) therap......
小提示:本篇文献需要登录阅读全文,点击跳转登录